PlainRecalls
FDA Drug Low Class III Terminated

Benzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bangaluru -560076 India, Distributed by Strides Pharma Inc East Brunswick, NJ 08816, NDC 64380-713-06

Reported: May 31, 2017 Initiated: May 9, 2017 #D-0858-2017

Product Description

Benzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bangaluru -560076 India, Distributed by Strides Pharma Inc East Brunswick, NJ 08816, NDC 64380-713-06

Reason for Recall

Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.

Details

Recalling Firm
Strides Pharma INC
Units Affected
127,517 bottles
Distribution
U.S.A. Nationwide
Location
East Brunswick, NJ

Frequently Asked Questions

What product was recalled?
Benzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bangaluru -560076 India, Distributed by Strides Pharma Inc East Brunswick, NJ 08816, NDC 64380-713-06. Recalled by Strides Pharma INC. Units affected: 127,517 bottles.
Why was this product recalled?
Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 31, 2017. Severity: Low. Recall number: D-0858-2017.